Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Lenox Pasifik Investama Tbk. (LPPS) vs Charlie Hospital Semarang Tbk. (RSCH)

Lenox Pasifik Investama Tbk.Trading
Charlie Hospital Semarang Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Lenox Pasifik Investama Tbk. dan Charlie Hospital Semarang Tbk.: Lenox Pasifik Investama Tbk. diperdagangkan di Rp79 (kapitalisasi pasar 181,18 M, volume 24 jam 76,86 jt), sedangkan Charlie Hospital Semarang Tbk. diperdagangkan di Rp258 (kapitalisasi pasar 678,4 M, volume 24 jam 25,57 jt). Perbedaan utamanya: Charlie Hospital Semarang Tbk. jauh lebih besar — sekitar 3,7× kapitalisasi pasar Lenox Pasifik Investama Tbk., dan Lenox Pasifik Investama Tbk. lebih aktif diperdagangkan (76,86 jt vs 25,57 jt). Mana yang lebih baik tergantung tujuan investasimu.

LPPSRSCH
Kapitalisasi Pasar
181,18 M678,4 M
Volume
76,86 jt25,57 jt
Lot
768,6 rb255,67 rb
Perputaran
6,58 M6,57 M
Harga Rata-rata
85,59256,8
Nilai Transaksi
6,58 M6,57 M
Harga Ekuilibrium Indikatif
79258
Volume Ekuilibrium Indikatif
9,22 rb110

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

LPPS
Lihat detail
RSCH
Lihat detail

Tentang Lenox Pasifik Investama Tbk.

PT Lippo Securities Tbk (the Parent Company) was established on June 20, 1989 based on notarial deed No.514 of Misahardi Wilamarta, S.H. The deed of establishment was approved by the Ministry of Justice of the Republic of Indonesia (MOJ) in its decision letter No.C2-6029.HT.01.01TH.89 dated July 6, 1989, and was published in the State of Gazette No.80 Supplement No. 3904 dated October 5, 1990. Its articles of association has been amended several times, most recently by notarial deed No.113 of Ny. Poerbaningsih Asi Warsito, S.H., dated July 30,1999, concerning among others, the adjustments to effect the Regulation No.IX.D.I. On December 20, 1999, the Parent Company submitted a letter to the Chief of the Capital Market Supervisory Board requesting for the revocation of its business license as broker, in connection with the merger of its brokering activities with PT Ciptadana Sekuritas, a subsidiary. This request was approved by the Chief of the Capital Market Supervisory Board based on its decision letter No. 01/PM/2000 dated January 5, 2000.In view of the foregoing, PT Bursa Efek Jakarta in its letter No.S.024/BEJ.ANG/01-2000 dated January 12, 2000 and PT Bursa Efek Surabaya in its letter No. T1-003/AGT/BES/I/2000 dated January 1, 2000, cancelled their Approval Letter on Stock Exchange Membership (Surat Persetujuan Anggota Bursa) issued to the Parent Company effective January 13, 2000 and January 4, 2000, respectively. Accordingly, the Parent Company is required to sell its investments in shares of stock of PT Bursa Efek Jakarta and PT Bursa Efek Surabaya.

Selengkapnya di halaman LPPS

Tentang Charlie Hospital Semarang Tbk.

PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.

Selengkapnya di halaman RSCH